<DOC>
	<DOCNO>NCT01904045</DOCNO>
	<brief_summary>Aim study investigate whether patient follow kidney transplantation ( &gt; 6 month transplantation ) , intra-patient variability level tacrolimus comparable administration tacrolimus twice daily ( Prograf ) tacrolimus daily ( Advagraf ) , regimen 3 month .</brief_summary>
	<brief_title>PEL-1235_REN-0176-I</brief_title>
	<detailed_description />
	<mesh_term>Tacrolimus</mesh_term>
	<criteria>sign write informed consent male female patient â‰¥ 18years age Patient receive kidney transplantation least 6 month prior inclusion study No acute rejection episode least 3 month PRG level dose stable least 1 month Patient capable understand purpose risk study , fully inform give write informed consent participate study Acute rejection episode within last 3 month prior study entry Unstable PRG trough level dose change month study entry History noncompliance medical regimen Patients unwilling unable comply protocol Treatment another investigational product study last 30 day prior study start</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2016</verification_date>
</DOC>